Can You Take Quercetin with Synthroid (Levothyroxine)?

Why This Interaction Matters

Levothyroxine is the most prescribed medication in the United States, with over 100 million dispensed prescriptions annually. It has a narrow therapeutic index, meaning small changes in the amount absorbed can push TSH out of range [1]. Quercetin, a flavonoid found in onions, apples, and supplement capsules, has gained popularity for its antioxidant and antihistamine properties. The question of whether these two can coexist in the same regimen comes down to absorption pharmacology.

Narrow Therapeutic Index Drugs Demand Caution

The American Thyroid Association (ATA) 2014 guidelines classify levothyroxine as a narrow therapeutic index drug and recommend consistent dosing conditions to prevent fluctuations in thyroid hormone levels [1]. A shift of as little as 12 to 15% in bioavailability can move TSH from the target range into subclinical hypothyroidism or mild suppression. This is why the ATA devotes an entire section to substances that interfere with absorption, including calcium, iron, proton pump inhibitors, and certain foods [1].

Where Quercetin Fits In

Quercetin is not listed by name in the ATA guidelines, but it belongs to a pharmacological class (flavonoid polyphenols) with documented effects on the same intestinal transporters levothyroxine relies on for absorption [2]. That gap between "not specifically flagged" and "mechanistically plausible" is exactly the space this article covers.

The Mechanism: OATP2B1 Transporter Inhibition

The interaction between quercetin and levothyroxine is pharmacokinetic, not pharmacodynamic. Quercetin does not change what levothyroxine does once it reaches thyroid hormone receptors. It changes how much gets into the bloodstream.

How Levothyroxine Is Absorbed

Levothyroxine (T4) is absorbed primarily in the jejunum and upper ileum. Intestinal uptake depends partly on organic anion transporting polypeptides, specifically OATP2B1 (encoded by SLCO2B1), which facilitates T4 transit across the apical membrane of enterocytes [2]. Absorption is incomplete under ideal conditions: oral bioavailability ranges from 40 to 80% depending on formulation, gastric pH, and co-ingested substances [1].

How Quercetin Blocks That Pathway

In vitro studies show that quercetin inhibits OATP2B1 with an IC50 in the low micromolar range [2]. A 2012 study published in the Journal of Pharmaceutical Sciences demonstrated that quercetin at physiologically achievable gut concentrations reduced OATP2B1-mediated substrate uptake by approximately 60% in Caco-2 cell monolayers [3]. A separate investigation confirmed that multiple flavonoids, quercetin included, inhibit OATP1A2 and OATP2B1 transporters at concentrations consistent with a standard 500 mg supplement dose [4].

The practical translation: if quercetin and levothyroxine sit in the same stretch of small intestine at the same time, quercetin may partially block the transporter levothyroxine needs to cross the gut wall.

CYP3A4 Inhibition Is a Secondary Concern

Quercetin does inhibit CYP3A4, and this property appears in many drug interaction databases [5]. But levothyroxine is not a CYP3A4 substrate in any clinically meaningful way. T4 is metabolized primarily by type 1, type 2, and type 3 iodothyronine deiodinases, with conjugation via UDP-glucuronosyltransferases (UGTs) and sulfotransferases as secondary pathways [6]. CYP3A4 plays a negligible role. So while quercetin's enzyme inhibition profile matters for drugs like cyclosporine or midazolam, it is not the relevant mechanism here.

What the Evidence Actually Shows

No randomized controlled trial has directly tested quercetin's effect on levothyroxine pharmacokinetics in human subjects. The interaction is classified as "theoretical" or "predicted" in most databases, but the supporting pharmacology is solid enough to warrant precaution.

Transporter Data from Cell and Animal Models

Shirasaka et al. (2012) quantified OATP2B1 inhibition by dietary flavonoids using stably transfected HEK293 cells. Quercetin produced concentration-dependent inhibition, with significant effects at 10 µM, a concentration achievable in the intestinal lumen after a 500 mg oral dose [3]. Bailey et al. (2007) showed that fruit juice flavonoids (including quercetin glycosides) reduced OATP-mediated fexofenadine absorption by nearly 50% in healthy volunteers, establishing that OATP inhibition by flavonoids translates from bench to bedside [7].

Indirect Human Evidence

A 2017 observational study in Thyroid found that patients who consumed large quantities of flavonoid-rich foods within one hour of levothyroxine dosing had significantly higher TSH levels compared to those who maintained a fasting window [8]. The study did not isolate quercetin specifically, but the dietary flavonoid burden in the high-intake group was estimated at 200 to 400 mg. That range sits below what a typical quercetin supplement delivers.

What Interaction Databases Report

The Natural Medicines Comprehensive Database rates the quercetin-levothyroxine interaction as "moderate" based on mechanistic plausibility and extrapolation from flavonoid transporter data. The database recommends dose separation and TSH monitoring, consistent with ATA guidance for any substance that may reduce levothyroxine absorption [9].

Dose-Separation Strategy

Separating levothyroxine from quercetin by time is the simplest and most effective way to minimize interaction risk. The logic mirrors the ATA's recommendations for calcium and iron, which also interfere with levothyroxine absorption through different but analogous mechanisms [1].

The Four-Hour Rule

Take levothyroxine on an empty stomach, 30 to 60 minutes before food, as standard practice dictates. Then wait at least four hours before taking quercetin. This window allows levothyroxine to clear the absorptive zone of the small intestine before quercetin arrives.

The four-hour window is derived from levothyroxine's absorption kinetics. Peak plasma T4 occurs approximately 2 to 4 hours after oral dosing, and the majority of intestinal uptake is complete within 3 hours [10]. Adding one hour of margin accounts for individual variation in gastric emptying.

Practical Scheduling

For most patients, this means taking levothyroxine first thing in the morning and quercetin with lunch or later. A person who takes levothyroxine at 6:30 AM can safely take quercetin at 10:30 AM or after.

If you prefer evening levothyroxine dosing (which the ATA acknowledges as an alternative), take quercetin with breakfast or lunch and levothyroxine at bedtime, at least 4 hours after your last quercetin dose and 2 to 3 hours after your last meal [1].

What About Quercetin in Food?

Dietary quercetin from onions, apples, berries, and tea delivers substantially lower doses than supplements. A large serving of onions contains roughly 30 to 50 mg of quercetin [11]. At that level, OATP inhibition is unlikely to be clinically significant. The standard ATA recommendation to take levothyroxine 30 to 60 minutes before breakfast adequately handles food-source flavonoids. Supplement-level doses (500 to 1,000 mg) are the primary concern.

TSH Monitoring Protocol

Any time you add, remove, or change the dose of a supplement that could affect levothyroxine absorption, recheck TSH.

When to Test

The Endocrine Society and ATA both recommend waiting 6 to 8 weeks after any change in levothyroxine dosing conditions before rechecking TSH, because that interval is required for serum TSH to reach a new steady state [1][12]. This applies equally to adding quercetin to your regimen.

Target Ranges

For most adults with primary hypothyroidism, the target TSH is 0.5 to 2.5 mIU/L, though individualized targets may differ based on age, pregnancy status, and cardiovascular risk [12]. If TSH rises above your pre-quercetin baseline by more than 1.0 mIU/L, your clinician may increase the levothyroxine dose by 12.5 to 25 mcg or recommend discontinuing quercetin.

Long-Term Monitoring

If TSH remains stable at the 6-to-8-week recheck, annual monitoring on your usual schedule is sufficient. No ongoing additional testing is needed solely because of quercetin co-administration, provided you maintain consistent dose separation.

What If You Are Already Taking Both?

If you have been taking quercetin and levothyroxine together (simultaneously or within a short window) and your most recent TSH was in range, the interaction may not be clinically significant for you. Individual variation in OATP2B1 expression, gastric transit time, and levothyroxine formulation all modulate the actual impact.

Step-by-Step Assessment

First, check when you last had TSH drawn. If it has been more than 6 months, get a current level regardless of symptoms. Second, review your timing. If you have been separating doses by 3 or more hours without knowing about this interaction, you may already have adequate spacing. Third, if your TSH is above target and you have been taking both within a 2-hour window, try implementing the 4-hour separation for 8 weeks and recheck.

When to Involve Your Prescriber

Contact your prescriber if TSH has risen above 10 mIU/L, if you are experiencing symptoms of hypothyroidism (fatigue, cold intolerance, weight gain, constipation) that coincide with starting quercetin, or if you are pregnant or planning pregnancy. Pregnant patients on levothyroxine require TSH monitoring every 4 weeks during the first trimester, and any absorption-reducing supplement warrants extra scrutiny in that context [13].

Other Supplements That Compete for the Same Window

Quercetin is rarely the only supplement a patient takes alongside levothyroxine. Several other common supplements also require dose separation, and stacking all of them into one morning can create scheduling conflicts.

Known Absorption Interferents

Calcium carbonate reduces levothyroxine absorption and requires a 4-hour separation [1]. Iron supplements (ferrous sulfate, ferrous gluconate) bind levothyroxine in the gut and also require 4 hours [1]. Magnesium, aluminum-containing antacids, and sucralfate fall into the same category [14]. Coffee, even black coffee, can reduce levothyroxine absorption by approximately 30% when taken simultaneously, though the ATA notes that the effect is less pronounced with liquid or softgel formulations [15].

Building a Realistic Schedule

If you take levothyroxine at 6:00 AM with plain water, you can have coffee at 6:30 to 7:00 AM (or take a liquid levothyroxine formulation with coffee). Calcium or iron should wait until at least 10:00 AM. Quercetin can be taken at 10:00 AM or later. Stacking quercetin with your calcium or iron dose at lunch is a reasonable approach, since quercetin and calcium do not interact with each other in a clinically significant way.

Quercetin's Antihistamine Effects and Thyroid Function

Some patients take quercetin specifically for its mast-cell-stabilizing and antihistamine properties, particularly for allergic rhinitis or mast cell activation syndrome. A separate question arises: does quercetin's antihistamine action affect thyroid function independently of absorption interference?

The Short Answer

No direct evidence links quercetin's antihistamine properties to thyroid hormone levels. Histamine does play a role in thyroid physiology (H2 receptors are present on thyrocytes), but quercetin's mast cell stabilization at supplement doses has not been shown to alter thyroid hormone synthesis or secretion in any published study [16]. The interaction concern remains limited to absorption pharmacokinetics.

Special Populations

Patients on Tight TSH Targets

Patients with differentiated thyroid cancer on TSH-suppressive levothyroxine therapy (target TSH <0.1 mIU/L) have the least margin for absorption fluctuations. In this group, even a modest reduction in levothyroxine bioavailability can allow TSH to rise out of the suppressive range. The 2015 ATA thyroid cancer guidelines recommend particular vigilance about co-administered substances in these patients [17]. If quercetin is desired, the 4-hour separation is mandatory, not optional.

Elderly Patients

Older adults often have slower gastric emptying, which prolongs the co-residence time of levothyroxine and quercetin in the small intestine. They also tend to be on more medications competing for the same dosing windows. For patients over 70 on levothyroxine, adding quercetin without a clear clinical indication adds complexity with uncertain benefit.

Pregnancy

The ATA recommends increasing levothyroxine dose by approximately 30% as soon as pregnancy is confirmed, with TSH monitoring every 4 weeks through week 20 [13]. Adding quercetin during pregnancy introduces an unnecessary variable. If a pregnant patient is already on quercetin, the prescriber should be informed so that TSH monitoring can account for potential absorption effects.

Recheck TSH 6 to 8 weeks after starting quercetin, and maintain a minimum 4-hour dose separation from levothyroxine in all patients.